All News

When cancer entered our life, fear was a constant. However, we tried to live as joyously as possible between check-ups.

He dreams that this ever-growing body of knowledge will progressively improve the ability to understand and treat cancer; multiple myeloma has been at the center of this dream.

While the large cancer hospitals do amazing work, I am extremely grateful for my local cancer center.

One expert explains how the road to cancer drug development isn’t a smooth one, but progress can be made nonetheless.

Data demonstrate that iberdomide alone or in combination with other treatments may be a promising option for patients with relapsed/refractory lymphoma.

Although triplet therapy may be effective and tolerable for patients with BRAF-mutant melanoma, each patient’s case should be considered before deciding if it is the right course of treatment, according to an expert.

Recent study results showed that patients with advanced HER2-positive breast cancer lived longer without disease progression when treated with Enhertu compared to when treated with Xeloda.

Imfinzi alone or combined with Imjudo may improve survival and tumor response when administered before surgery, opening the door to neoadjuvant mesothelioma treatments.

Some patients are at higher risk of infection, so it’s critical that they keep their care team up to date on any symptoms.

After being diagnosed with cancer, my love for December is not just Christmas.

From investigative journalist, Drew Griffin’s cancer-related death to Jane Fonda’s lymphoma update, here’s what’s happening in the oncology space this week.

Patients with relapsed/refractory follicular lymphoma — a group that traditionally has limited treatment options — now have a new bispecific antibody available.

The past 20 years have brought great advances to advocacy groups, helping to improve patients’ quality of life. But more work is needed to raise awareness in underserved groups.

It is important that caregivers take care of not only the patient, but also themselves, as the diagnosis may affect their mental health.

No matter how grateful I feel this holiday season, I fear that my daughter’s no evidence of disease status was just a roll of the dice — and another roll can take us back to the world of cancer.

A childhood cancer survivor now works raising funds for Children’s Hospital of Philadelphia, the same hospital where she received treatment for Ewing sarcoma at 12 years old.

If approved by the FDA, zanidatamab could be the first HER-2 targeted therapy for patients with biliary tract cancers.

"We call ourselves the wolf pack. ... It is kind of tongue in cheek, but there is some seriousness behind how we view each other in terms of having each other’s backs,” said Trevor Maxwell, a stage 4 colon cancer survivor and the founder of Man Up to Cancer.

An expert explains what the FDA’s accelerated approval of Krazati means for patients with KRAS G12C-mutant locally advanced or metastatic non-small cell lung cancer and what he hopes will come next.

During this holiday season, lighting candles in remembrance and in honor of those who need a little light on their cancer journeys helps me cope, too.

As part of its Speaking Out video series, CURE® spoke with Michael J. Rovito, on behalf of the Testicular Cancer Foundation, about survivorship.

Treat yourself without the guilt! Here are three delicious — and most importantly nutritious — desserts to try at home when you are craving something sweet.

From updates on clinical trials to a podcast where an oncology nurse shares how her son’s leukemia diagnosis changed her life, here are CURE®’s top blood cancer articles from the year 2022.

After undergoing a mastectomy, women can either proceed with reconstruction or "go flat," but one expert says that the correct decision is what’s best for the patient.

As I work on a holiday drawing, the coyotes are howling outside, while inside, my cat and I are reminded of my wife who died of breast cancer.

CURE® surveyed its audience to see which terms they prefer using when describing their cancer experiences. Some people who have experienced cancer explained why they dislike certain labels.

HIF-2 alpha inhibitors are transforming therapy for patients with renal cell carcinoma and von Hippel-Lindau disease.

Take a look at the top advancements and most popular articles about kidney cancer from the year 2022.